WinRho® eDetail
An Updated Look at ITP Treatment
Marc Salit, Ph.D., Baxter Medical Affairs, narrates this eDetail.
Drawing from years of experience researching ITP and educating other physicians, Dr. Salit gives a brief overview of ITP and explains how the latest research may impact your prescribing decisions.
This presentation is separated into two sections: Adult and Pediatric ITP. In both, Dr. Salit explains the incidence of ITP, introduces front-line therapies including WinRho®, and provides efficacy data, duration of response, and infusion time information.
If you share his passion for treating ITP, or if you simply want to learn more about ITP or WinRho®, please take ten minutes and view the eDetail. The information will illustrate exactly why WinRho® should be your first choice for treating ITP.
The following eDetail gives a thorough explanation of immune thrombocytopenic purpura (ITP) and WinRho®, an effective front-line therapy.
This eDetail requires audio
